S H Bakker1, W C H Jacobs2, W Pondaag2, H Gelderblom3, R A Nout4, P D S Dijkstra5, W C Peul2, C L A Vleggeert-Lankamp2. 1. Department of Neurosurgery, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands. s.h.bakker@lumc.nl. 2. Department of Neurosurgery, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands. 3. Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands. 4. Departmant of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands. 5. Department of Orthopedic Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Abstract
BACKGROUND AND AIMS: The aim of this systematic review is to describe the epidemiology of chordoma and to provide a clear overview of clinical prognostic factors predicting progression-free and overall survival. METHODS: Four databases of medical literature were searched. Separate searches were performed for each of the two objectives. Reference and citation tracking was performed. Papers were processed by two independent reviewers according to a protocol that included risk of bias analysis. Disagreement was resolved by discussion. Pooled analyses were planned if homogeneity of data would allow. RESULTS: Incidence-incidence rates ranged between 0.18 and 0.84 per million persons per year and varied between countries and presumably between races. On average patients were diagnosed in their late fifties and gender data indicate clear male predominance. Two of the largest studies (n = 400 and n = 544) reported different anatomical distributions: one reporting the skull base and sacrococcygeal area affected in 32% and 29% of cases, whereas the other reporting that they were affected in 26% and 45% of cases, respectively. PROGNOSTIC FACTORS: Statistically significant adverse prognostic factors predicting progression-free and overall survival include female sex, older age, bigger tumour size, increasing extent of tumour invasion, non-total resection, presence of metastasis, local recurrence, and dedifferentiated histological subtype. CONCLUSIONS: Incidence rate and anatomical distribution vary between countries and presumably between races. Most chordomas arise in the skull base and sacrococcygeal spine, and the tumour shows clear male predominance. Multiple adverse prognostic factors predicting progression-free and overall survival were identified in subgroups of patients. These slides can be retrieved under Electronic Supplementary Material.
BACKGROUND AND AIMS: The aim of this systematic review is to describe the epidemiology of chordoma and to provide a clear overview of clinical prognostic factors predicting progression-free and overall survival. METHODS: Four databases of medical literature were searched. Separate searches were performed for each of the two objectives. Reference and citation tracking was performed. Papers were processed by two independent reviewers according to a protocol that included risk of bias analysis. Disagreement was resolved by discussion. Pooled analyses were planned if homogeneity of data would allow. RESULTS: Incidence-incidence rates ranged between 0.18 and 0.84 per million persons per year and varied between countries and presumably between races. On average patients were diagnosed in their late fifties and gender data indicate clear male predominance. Two of the largest studies (n = 400 and n = 544) reported different anatomical distributions: one reporting the skull base and sacrococcygeal area affected in 32% and 29% of cases, whereas the other reporting that they were affected in 26% and 45% of cases, respectively. PROGNOSTIC FACTORS: Statistically significant adverse prognostic factors predicting progression-free and overall survival include female sex, older age, bigger tumour size, increasing extent of tumour invasion, non-total resection, presence of metastasis, local recurrence, and dedifferentiated histological subtype. CONCLUSIONS: Incidence rate and anatomical distribution vary between countries and presumably between races. Most chordomas arise in the skull base and sacrococcygeal spine, and the tumour shows clear male predominance. Multiple adverse prognostic factors predicting progression-free and overall survival were identified in subgroups of patients. These slides can be retrieved under Electronic Supplementary Material.
Authors: A E Rosenberg; G P Nielsen; S B Keel; L G Renard; M M Fitzek; J E Munzenrider; N J Liebsch Journal: Am J Surg Pathol Date: 1999-11 Impact factor: 6.394
Authors: Wouter A Moojen; Carmen L A Vleggeert-Lankamp; Augustinus D G Krol; Sander P D Dijkstra Journal: Spine (Phila Pa 1976) Date: 2011-05-01 Impact factor: 3.468
Authors: A Terahara; A Niemierko; M Goitein; D Finkelstein; E Hug; N Liebsch; D O'Farrell; S Lyons; J Munzenrider Journal: Int J Radiat Oncol Biol Phys Date: 1999-09-01 Impact factor: 7.038
Authors: Joseph H Schwab; John H Healey; Peter Rose; Jorge Casas-Ganem; Patrick J Boland Journal: Spine (Phila Pa 1976) Date: 2009-11-15 Impact factor: 3.468
Authors: Jordan C Xu; Brandon M Lehrich; Tyler M Yasaka; Brendan M Fong; Frank P K Hsu; Edward C Kuan Journal: Childs Nerv Syst Date: 2021-01-18 Impact factor: 1.475
Authors: Bing Xia; Kajal Biswas; Tzeh K Foo; Thiago T Gomes; Maximilian Riedel-Topper; Eileen Southon; Zhihua Kang; Yanying Huo; Susan Reid; Stacey Stauffer; Weiyin Zhou; Bin Zhu; Hela Koka; Sally Yepes; Seth A Brodie; Kristine Jones; Aurelie Vogt; Bin Zhu; Brian Carter; Neal D Freedman; Belynda Hicks; Meredith Yeager; Stephen J Chanock; Fergus Couch; Dilys M Parry; Alvaro N Monteiro; Alisa M Goldstein; Marcelo A Carvalho; Shyam K Sharan; Xiaohong R Yang Journal: Hum Mutat Date: 2022-07-12 Impact factor: 4.700
Authors: Peter Obid; Tamás Fekete; Philipp Drees; Daniel Haschtmann; Frank Kleinstück; Markus Loibl; Dezsö Jeszenszky Journal: Eur Spine J Date: 2021-08-02 Impact factor: 3.134
Authors: J D Palmer; M E Gamez; K Ranta; H Ruiz-Garcia; J L Peterson; D M Blakaj; D Prevedello; R Carrau; A Mahajan; K L Chaichana; D M Trifiletti Journal: J Neurooncol Date: 2020-08-12 Impact factor: 4.130
Authors: Jeffrey I Traylor; Hadley E Sheppard; Visweswaran Ravikumar; Jonathan Breshears; Shaan M Raza; Charles Y Lin; Shreyaskumar R Patel; Franco DeMonte Journal: Neurosurgery Date: 2021-01-13 Impact factor: 5.315